European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)
Active, not recruitingNCT06495177
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this observational study is to provide a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary heart disease (CHD), individuals at high cardiovascular disease risk and all those with hypertension, dyslipidaemia (including familial hypercholesterolaemia), diabetes and dysglycaemia and chronic kidney disease (CKD) and determine whether the European guidelines on cardiovascular disease prevention, hypertension, lipids, diabetes and chronic kidney disease are being followed.
Study details
- Official title
- European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease
- Conditions
- Coronary Disease
- Acute Coronary Syndrome
- Unstable Angina
- ST Elevation Myocardial Infarction
- Non-ST Elevation Myocardial Infarction
- Sponsor
- European Society of Cardiology
- Collaborators
- National Institute for Prevention and Cardiovascular Health, Ireland
- Start date
- 2024-06-07
- Primary completion
- 2026-03-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients having signed an informed Consent * Patients aged from 18 years old at the time of identification * At least six and at most 24 months elapsed between the index event (the recruiting diagnostic or treatment criteria below) and the date of interview * Patients meeting the recruiting diagnostic or treatment criteria: * Coronary patients: Acute coronary events (acute coronary syndrome {STEMI or NSTEMI}, unstable angina) or an emergency or elective revascularisation for coronary artery disease (CABG, PCI) * High cardiovascular disease (CVD) risk patients: patients free of CVD, who have been prescribed one or more of the following treatments: blood pressure and/or lipid-lowering and/or glucose lowering (diet and/or hypoglycaemic agents and/or insulin) Exclusion Criteria: * Patients living outside defined geographical areas * Patients admitted to hospital from outside the geographical area or under the care of cardiologists in hospitals that do not participate in EUROASPIRE VI
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06495177